$ALIM Recent Headlines Top longs and shorts to watch

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ALIM Recent Headlines

Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Feb. 28, 2012 - Kate Gibson
Friday’s biggest gaining and declining stocks 6:06 p.m. Nov. 11, 2011 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:30 p.m. Dec. 27, 2010 - Kate Gibson
Alimera, pSivida slammed by FDA move 2:30 p.m. Dec. 27, 2010 - Val Brickates Kennedy
Alimera, pSivida crushed by FDA setback 9:36 a.m. Dec. 27, 2010 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 3:48 p.m. Aug. 31, 2010 - MarketWatch
Alimera, pSivida, Bayer lead drug-stock rally 12:15 p.m. Aug. 31, 2010 - Val Brickates Kennedy
Alimera leads drug stocks higher 9:21 a.m. Aug. 31, 2010 - Val Brickates Kennedy
Alimera Sciences shares jump 9.3% on FDA move 8:34 a.m. Aug. 31, 2010 - Laura Mandaro
Alimera jumps on FDA update 8:28 a.m. Aug. 31, 2010 - Val Brickates Kennedy
Javelin rockets as drug stocks head south 2:41 p.m. June 29, 2010 - Val Brickates Kennedy
Three tech companies highlight busy IPO day 4:30 p.m. April 22, 2010 - Benjamin Pimentel
Baxter, Affymetrix lead drug stocks lower 1:05 p.m. April 22, 2010 - Val Brickates Kennedy

Final Guidance from NICE for pSivida's Iluvien - Analyst Blog 5:00 p.m. Dec. 5, 2013 - Zacks.com
Iluvien, Lucentis get NICE nod 9:38 a.m. Nov. 27, 2013 - Seeking Alpha
Ampio Hides Need For New Eye Drug Study in SEC Filing 8:03 a.m. Nov. 25, 2013 - TheStreet.com
Alimera Sciences Inc. is now in Oversold Territory - Tale of the Tape 8:48 a.m. Nov. 15, 2013 - Zacks.com
10-Q: ALIMERA SCIENCES INC 9:14 a.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Alimera Sciences Management Discusses Q3 2013 Results - Earnings Call Transcript 6:40 p.m. Nov. 11, 2013 - Seeking Alpha
Alimera Down on 3rd Iluvien CRL - Analyst Blog 5:10 p.m. Oct. 21, 2013 - Zacks.com
PSivida: Thoughts In The Aftermath Of The Complete Response Letter On Iluvien 4:13 p.m. Oct. 20, 2013 - Seeking Alpha
pSivida, Alimera and Ariad Join Bio-Implosion Watch 7:52 a.m. Oct. 18, 2013 - 247WallSt.com
Alimera Sciences Receives FDA CRL for ILUVIEN 4:31 a.m. Oct. 18, 2013 - benzinga.com
PSivida: Previewing The Possible Effect On The Stock Of The October 17th PDUFA Date For Iluvien 6:57 p.m. Oct. 7, 2013 - Seeking Alpha
pSivida Corporation: Strong Takeover Target, October 17th PDUFA Date Make It A Buy 3:00 a.m. Oct. 7, 2013 - Seeking Alpha
Five FDA Approvals and Reviews at Risk Under a Government Shutdown 8:49 a.m. Sept. 30, 2013 - 247WallSt.com
A Closer Look At PSivida's Pipeline 4:31 p.m. Sept. 16, 2013 - Seeking Alpha
5 Pharmaceutical Stocks to Buy Now 7:45 a.m. Aug. 30, 2013 - InvestorPlace.com
10-Q: ALIMERA SCIENCES INC 6:03 p.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Alimera Sciences Management Discusses Q2 2013 Results - Earnings Call Transcript 5:10 p.m. Aug. 12, 2013 - Seeking Alpha
Keep An Eye On ICo Therapeutics 10:47 a.m. July 29, 2013 - Seeking Alpha
France's Transparency Commission Issues Positive Opinion For Reimbursement Of ILUVIEN® 5:35 a.m. July 24, 2013 - benzinga.com
pSivida Up on Phase I/II Interim Data - Analyst Blog 4:10 p.m. July 16, 2013 - Zacks.com


U.K.'s NICE Issues Final Guidance Recommending Alimera Sciences' ILUVIEN® 7:00 a.m. Dec. 2, 2013 - PR Newswire
Alimera Sciences Reports Third Quarter 2013 Financial Results 4:05 p.m. Nov. 11, 2013 - PR Newswire
Alimera Sciences to Release Third Quarter 2013 Results and Provide Update on Upcoming FDA Advisory Committee Meeting 5:30 a.m. Oct. 31, 2013 - PR Newswire
pSivida Reports Complete Response Letter From FDA for ILUVIEN(R) 5:33 a.m. Oct. 18, 2013 - BusinessWire
Alimera Sciences Receives Complete Response Letter For ILUVIEN® 5:30 a.m. Oct. 18, 2013 - PR Newswire
U.K.'s NICE Issues Final Appraisal Determination Recommending Alimera's ILUVIEN® for Chronic Diabetic Macular Edema 6:01 p.m. Sept. 30, 2013 - PR Newswire
Alimera Sciences Reports Second Quarter 2013 Financial Results 3:05 p.m. Aug. 12, 2013 - PR Newswire
Alimera Sciences to Release Second Quarter Fiscal Year 2013 Financial Results 3:05 p.m. Aug. 5, 2013 - PR Newswire
France's Transparency Commission Issues Positive Opinion For Reimbursement Of ILUVIEN? 6:30 a.m. July 24, 2013 - PR Newswire
Alimera Sciences Added To Russell 2000?, 3000? And Global Indexes 5:30 a.m. July 1, 2013 - PR Newswire
Alimera Sciences Announces Issuance Of A Positive Appraisal Recommendation On ILUVIEN? For Consultation In The United Kingdom 5:30 a.m. June 14, 2013 - PR Newswire
pSivida Corp President and CEO, Dr. Paul Ashton Publishes New Blog Entitled ''Big and Small Picture'' 7:30 a.m. May 23, 2013 - ACCESSWIRE
pSivida Corp. Reports Third Quarter Fiscal Year 2013 Results 3:00 p.m. May 13, 2013 - BusinessWire
Alimera Sciences Reports First Quarter 2013 Financial Results 3:05 p.m. May 9, 2013 - PR Newswire
Alimera Sciences Secures $20 Million Debt Facility 7:00 a.m. May 8, 2013 - PR Newswire
pSivida Corp. Announces Commercial Launch of ILUVIEN(R) in Germany with First Patient Treated 3:14 p.m. May 7, 2013 - BusinessWire
Alimera Sciences Announces First Patient Treated With Commercially Available ILUVIEN? 3:01 p.m. May 7, 2013 - PR Newswire
Alimera Sciences To Release First Quarter Fiscal Year 2013 Financial Results 12:20 p.m. May 3, 2013 - PR Newswire
pSivida Corp. Announces New ILUVIEN(R) PDUFA Date of October 17, 2013 7:01 a.m. May 1, 2013 - BusinessWire
Alimera Sciences Announces New PDUFA Date For ILUVIEN? 7:00 a.m. May 1, 2013 - PR Newswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Faces Lawsuit: Investor Unrest Unfolds

Updated Category News Views 5

Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...

Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach

Updated Category News Views 74

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 25

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 42

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Artprice Bridges Art and AI Across the Hispanic World

Updated Category News Views 11

A Monumental Launch with Deep Roots I've been around long enough to see all sorts of moves in the art world and the tech world. But what Artprice by Artmarket is pulling off here—it’s a doozy. Thierry Ehrmann’s “Diálogo entre un pensador y la IA” just went live in Spanish, and that’s not some paperback thrill ride. We’re talking about an 1,800-page piece of...

Continue Reading
Tulsa Hosts Gradient's Global Tech and Investment Event

Updated Category News Views 21

Tulsa's New Spotlight: Gradient's CHROMA Event Well, look at Tulsa, becoming the center of the tech and enterprise universe for a day. Gradient is throwing open the doors for its second annual CHROMA event on September 24, 2026. You might scratch your head and say, ‘Tulsa? Really?’ But hear me out—this isn’t just a local shindig. We're talking about a one-day...

Continue Reading
SOPHiA GENETICS' Q3 2026: Revenue Growth & Challenges

Updated Category News Views 7

Unpacking SOPHiA GENETICS' Third Quarter Figures Let's cut through the jargon and get straight to the brass tacks. SOPHiA GENETICS (NASDAQ:SOPH) just posted their third quarter numbers for 2026, and it’s a mixed bag, my friends. Sure, they boasted a 25% bump in revenue, hitting $24.3 million, but the devil's in the details—net losses nudged up to $20.3 million, not...

Continue Reading
Marathon Petroleum's Massive Q3 2026 Profit Surge

Updated Category News Views 13

Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...

Continue Reading
Newcomers, Veterans Elevate NYSE's Tokenization Efforts

Updated Category News Views 89

Breaking New Ground at the NYSE When the bell rings at the NYSE these days, it's not just marking the start of another trading session. It's the sound of change clanging its way onto Wall Street. On November 3, 2026, the NYSE threw its hat deeper into the tokenization ring, a game-changer perhaps. They've roped in some big guns—Securitize, tZERO, Broadridge Financial...

Continue Reading
Illumina's Role in Singapore's Precision Medicine Leap

Updated Category News Views 160

Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...

Continue Reading

Top 5 Most Recently Viewed Articles

Rising Demand and Technological Advancements in Krill Meal Market

Updated Category News Views 226

Understanding the Expanding Krill Meal Market The krill meal market is undergoing remarkable growth, fueled by a shift in consumer preferences favoring clean-label food products and natural flavor enhancers. According to recent estimates, the market is poised to expand significantly, reaching an impressive valuation by the end of an upcoming decade. This growth can be...

Continue Reading
Tango Therapeutics Begins Dosing in Pivotal Cancer Trial

Updated Category News Views 224

Tango Therapeutics Begins Dosing in Pivotal Cancer Trial BOSTON — Tango Therapeutics, Inc. (NASDAQ: TNGX), a dynamic biotechnology company dedicated to revolutionizing cancer care, has achieved a pivotal milestone by dosing the first patient in its TNG456 Phase 1/2 trial aimed at patients with MTAP-deleted solid tumors, particularly glioblastoma (GBM). Known for its...

Continue Reading
Investors Invited to Explore Class Action against Rentokil Initial

Updated Category News Views 188

Investors Encouraged to Join Class Action Against Rentokil Initial Bronstein, Gewirtz & Grossman, LLC, a well-respected law firm known for its expertise in securities cases, is reaching out to investors of Rentokil Initial Plc. This communication centers around a class action lawsuit that has been filed on behalf of those affected by some significant events concerning the...

Continue Reading
Murphy USA's Dividend Boost: A Commitment to Shareholders

Updated Category News Views 78

Murphy USA's Dividend Boost Reflects Confidence in Growth Murphy USA Inc. (NYSE: MUSA), a well-known player in the gasoline and convenience store sector, has recently announced an increase in its quarterly cash dividend. The company's Board has declared a new dividend of $0.48 per share, which represents a notable 6.7% rise from the previous dividend. This increase...

Continue Reading
Cloudinary Enhances Digital Asset Management with New Features

Updated Category News Views 181

Cloudinary's Innovative Update to Digital Asset Management Today, Cloudinary, the leading image and video platform, revealed significant advancements in its API-first digital asset management (DAM) solution. These enhancements are designed to address the evolving needs of brands in managing their visual assets efficiently and effectively. With a focus on streamlining...

Continue Reading